Yuling Shi

58PUBLICATIONS
87CO-AUTHORS
Personality and individual differencesNanotoxicology, health and safetySurface water quality processes and contaminated sediment assessmentPainAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Sep 24, 2026
Complete Skin Clearance is Associated with HADS-Defined Absence of Anxiety and Depressive Symptoms After IL-17A Inhibitor Treatment in Moderate-to-Severe Psoriasis: Evidence from the SPEECH Cohort.

|Jun 01, 2026
Development of Predictive Models for NB-UVB Treatment Efficacy and Safety in Psoriasis.

|May 12, 2026
Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation.

|Mar 16, 2026
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in patients with moderate-to-severe chronic spontaneous urticaria with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot study.

Xu Yao, Yi Liu, Yang Luo

|Jan 06, 2026
IL-27 signaling mediates skin inflammation in experimental psoriasis and atopic dermatitis.

Zeyu Chen, Lian Cui, Zhiyi Lan

|Oct 20, 2025
Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis.

Min Dai, Yuxiong Jiang, Yujing Xi

Pageof 10

Frequent Collaborators

9 joint publications

Dawei Huang

8 joint publications

Ying Li

6 joint publications

Jiajing Lu

6 joint publications

Chunyuan Guo